T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pavani Chalasani, MD
The University of Arizona Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arizona Cancer Center
Tucson, Arizona, United States
- Cedar-Sinai
Beverly Hills, California, United States
- University of Colorado Denver
Aurora, Colorado, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Mosaic Life Care
Saint Joseph, Missouri, United States
- University of New Mexico
Albuquerque, New Mexico, United States
- Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Oregon Health and Sciences University
Portland, Oregon, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- Jps Health Network
Fort Worth, Texas, United States
- Swedish Cancer Institute
Seattle, Washington, United States
- University of Washington
Seattle, Washington, United States
- University of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Dec 2018
- Primary completion
- 22 Dec 2022
- Completion
- 22 Dec 2022
- Last update posted
- 13 Aug 2024
- Registered enrollment
- 55
- Registry id
- NCT03530696
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.